Interested? Contact Us
SoftBank-backed Vir Biotechnology's shares tumble in market debut
Shares of SoftBank-backed Vir Biotechnology Inc plunged nearly 19.3% on their debut on Friday, adding to the gloom in the IPO market following WeWork's failed attempt to list on the stock market.
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
